Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Diabetes and Vascular Disease Research
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1479164109336041v1
6/4/223    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Conway, B.
Right arrow Articles by Orchard, T.
PubMed
Right arrow Articles by Conway, B.
Right arrow Articles by Orchard, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?

Baqiyyah Conway

University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA

Tina Costacou

University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA

Trevor Orchard

University of Pittsburgh, Department of Epidemiology, Pittsburgh, PA, USA, OrchardT{at}edc.pitt.edu

Although coronary artery disease (CAD) is the leading cause of death in type 1 diabetes (T1D), the mechanisms responsible for the greatly increased risk are poorly understood. In particular, the role of glycaemic control is controversial with one study suggesting it predicts CAD mortality but not incidence. In this analysis, of the Pittsburgh Epidemiology of Diabetes Complications study cohort of T1D, we examine whether risk factors differ for CAD morbidity and mortality, with a specific focus on HbA1c and insulin dose. Participants (n=592) were followed for 18 years for incident non-fatal and fatal CAD. Cox stepwise regression was used to determine the independent risk factors for non-fatal and fatal CAD. Mean age and diabetes duration at study baseline were 29 and 20 years, respectively. There were 109 incident non-fatal and 48 fatal CAD events. Baseline HbA1C was an independent risk factor for fatal CAD, along with duration of diabetes and albuminuria. In contrast, baseline lower insulin dose was strongly predictive of non-fatal CAD, as was lower renal function, higher diastolic blood pressure, and lipids. HbA1C predicts CAD mortality while lower insulin dose and standard CAD risk factors predict CAD morbidity.

Key Words: type 1 diabetes • coronary artery disease • insulin dose • glycaemic control • HbA1c • mortality

This version was published on October 1, 2009

Diabetes and Vascular Disease Research, Vol. 6, No. 4, 223-230 (2009)
DOI: 10.1177/1479164109336041


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?